News
2021
11/02
Facts & Figures
Scroll down or discover here: Facts & Figures generic medicines in Belgium - Facts & figures biosimilar medicines in Belgium
2020
09/11
e-PIL project 2020
With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission.
18/08
e-PIL project 2020: call for candidates
With the support of the Belgian and Luxembourg Competent Authorities, in 2018 the pharmaceutical industry launched the 'e-PIL' pilot project in Belgian and Luxembourg hospitals. The project is the result of a derogation obtained from the European Commission. In this pilot project, a selection of medicines on the Belgian and Luxembourg market are not accompanied by their patient paper inserted leaflet (PIL).
30/03
Treatment Covid-19: follow the scientific guidelines!
For the treatment of the Corona virus, Medaxes refers to the scientific guidelines issued by the scientific institutions of our country.
These informations are regularly updated, taking into account the latest scientific findings. For more information, please click on Sciensano Epidemio
2019
11/10
9 key ingredients to improve access to medicines in the hospital setting
A new report by KPMG titled ‘Improving healthcare delivery in hospitals by optimized utilization of medicines’ (08/10/2019) analyses the financing and procurement of medicines in hospitals in 8 European countries.
14/02
Medicines for Europe & Medaxes urge the EU institutions to adopt the SPC manufacturing waiver
Medicines for Europe and Medaxes urge the EU institutions to adopt the SPC manufacturing waiver for patients, sustainable healthcare and manufacturing jobs
04/02
European Falsified Medicines Directive (FMD) goes live 9 February
Video on the origins and application of this European Directive to combat the entry of falsified medicines into the legal supply chain. Also the Medaxes members fully support this Directive.
2018
21/06
FeBelGen makes way for Medaxes
FeBelGen, the association representing generic medicines companies since 2001, makes way for Medaxes, a broader umbrella organisation covering all medicines and self-care products that contribute to the accessibility of healthcare. In addition to generic and biosimilar medicines, Medaxes sees an increasingly prominent role ahead for properly framed self-care, through self-care medicines, self-care medical devices and food supplements freely available from pharmacies.